These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33775602)
21. Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Tomás M; Doumith M; Warner M; Turton JF; Beceiro A; Bou G; Livermore DM; Woodford N Antimicrob Agents Chemother; 2010 May; 54(5):2219-24. PubMed ID: 20194693 [TBL] [Abstract][Full Text] [Related]
22. Molecular analysis for the OprD gene among Pseudomonas aueroginosa clinical isolates obtained from hospitals in Jordan. Abu Khadra KM; Al-Rabaia SY; Khalil AM; Abu-Qatouseh LF; Abussaud MJ J Infect Dev Ctries; 2022 Apr; 16(4):683-690. PubMed ID: 35544631 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099 [TBL] [Abstract][Full Text] [Related]
24. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168 [TBL] [Abstract][Full Text] [Related]
25. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811 [TBL] [Abstract][Full Text] [Related]
26. PorinPredict: Biggel M; Johler S; Roloff T; Tschudin-Sutter S; Bassetti S; Siegemund M; Egli A; Stephan R; Seth-Smith HMB Microbiol Spectr; 2023 Jan; 11(2):e0358822. PubMed ID: 36715510 [TBL] [Abstract][Full Text] [Related]
27. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381 [TBL] [Abstract][Full Text] [Related]
28. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145 [TBL] [Abstract][Full Text] [Related]
29. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa. Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565 [TBL] [Abstract][Full Text] [Related]
30. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Li H; Luo YF; Williams BJ; Blackwell TS; Xie CM Int J Med Microbiol; 2012 Mar; 302(2):63-8. PubMed ID: 22226846 [TBL] [Abstract][Full Text] [Related]
31. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394 [TBL] [Abstract][Full Text] [Related]
32. Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Paulsson M; Singh B; Al-Jubair T; Su YC; Høiby N; Riesbeck K J Cyst Fibros; 2015 Sep; 14(5):600-7. PubMed ID: 26047937 [TBL] [Abstract][Full Text] [Related]
33. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Lee JY; Ko KS Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564 [TBL] [Abstract][Full Text] [Related]
34. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients. Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404 [TBL] [Abstract][Full Text] [Related]
35. Location of OprD porin in Pseudomonas aeruginosa clinical isolates. González-Vázquez MC; Rocha-Gracia RDC; Carabarín-Lima A; Bello-López E; Huerta-Romano F; Martínez-Laguna Y; Lozano-Zarain P APMIS; 2021 Apr; 129(4):213-224. PubMed ID: 33471435 [TBL] [Abstract][Full Text] [Related]
36. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. Wolter DJ; Hanson ND; Lister PD FEMS Microbiol Lett; 2004 Jul; 236(1):137-43. PubMed ID: 15212803 [TBL] [Abstract][Full Text] [Related]
37. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms]. Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Pirnay JP; De Vos D; Mossialos D; Vanderkelen A; Cornelis P; Zizi M Environ Microbiol; 2002 Dec; 4(12):872-82. PubMed ID: 12534469 [TBL] [Abstract][Full Text] [Related]
39. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals. Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901 [TBL] [Abstract][Full Text] [Related]
40. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]